Bioavailability of digoxin: what the clinician needs to know.
作者信息
Greenblatt D J, Duhme D W, Koch-Weser J, Smith T W
出版信息
Conn Med. 1974 May;38(5):230-2.
PMID:4831099
Abstract
摘要
相似文献
1
Bioavailability of digoxin: what the clinician needs to know.
Conn Med. 1974 May;38(5):230-2.
2
Evaluation of digoxin bioavailability in single-dose studies.
N Engl J Med. 1973 Sep 27;289(13):651-4. doi: 10.1056/NEJM197309272891302.
3
Non-equivalence of digoxin tablets.
Ann Clin Res. 1974;6(0):suppl 11:4-8.
4
[Metabolism and pharmacokinetics of lanatosides in man].
Dtsch Med Wochenschr. 1973 Jan 19;98(3):117-22. doi: 10.1055/s-0028-1106760.
5
Absorption of digoxin from different oral preparations in normal subjects during steady state.
Clin Pharmacol Ther. 1974 Aug;16(2):310-7. doi: 10.1002/cpt1974162310.
6
Dissimilarities of digoxin.
N Engl J Med. 1971 Dec 9;285(24):1376-7. doi: 10.1056/NEJM197112092852414.
7
The bioavailability of digoxin.
Lancet. 1972 Aug 12;2(7772):311-2.
8
Intravenous digoxin as a bioavailability standard: slow infusion and rapid injection.静脉注射地高辛作为生物利用度标准：缓慢输注和快速注射。
Clin Pharmacol Ther. 1974 May;15(5):510-3. doi: 10.1002/cpt1974155510.
9
Variation in biologic availability of digoxin from four preparations.四种制剂中地高辛生物利用度的差异。
N Engl J Med. 1971 Dec 9;285(24):1344-7. doi: 10.1056/NEJM197112092852403.
10
Digoxin tablet bioavailability: single-dose and steady-state assessment.
Ann Intern Med. 1974 Oct;81(4):469-74. doi: 10.7326/0003-4819-81-4-469.
Zotero 插件